Ocata Therapeutics Inc. OCAT
8.47 0.00 (+0.00%)
At closeJun 28, 2019, 6:07 PM EDT
8.45 Day range 8.48
3.06 52-week range 8.71
News
businesswire.com Ocata Therapeutics to Host Conference Call and Webcast to Provide
Corporate Update for the Third Quarter of 2015 MARLBOROUGH, Mass.--(BUSINESS WIRE)--Ocata Therapeutics, Inc. (NASDAQ: OCAT), a leader in the field of Regenerative Ophthalmology™ announced today that it will host a conference call on Monday,…
businesswire.com Ocata Therapeutics to Host Conference Call and Webcast to Provide
Corporate Update for the Second Quarter of 2015 MARLBOROUGH, Mass.--(BUSINESS WIRE)--Ocata Therapeutics, Inc. (NASDAQ: OCAT), a leader in the field of Regenerative Ophthalmology™, announced today that it will host a conference call on Thursday,…
businesswire.com Ocata Therapeutics to Host Conference Call and Webcast to Provide
Corporate Update for the First Quarter of 2015 MARLBOROUGH, Mass.--(BUSINESS WIRE)--Ocata Therapeutics, Inc. (“Ocata” or “the Company”; NASDAQ: OCAT), a leader in the field of Regenerative Ophthalmology™, announced today that it will host a…
businesswire.com Ocata Therapeutics to Host Conference Call and Webcast to Provide
Corporate Update for the Fourth Quarter and Full Year of 2014 MARLBOROUGH, Mass.--(BUSINESS WIRE)--Ocata Therapeutics, Inc. (“Ocata”; NASDAQ Global Market: OCAT), a clinical stage biotechnology company developing regenerative ophthalmology therapeutics,…